Ferring Pharmaceuticals is seeking a Commercial Lead – Uro‑Oncology to own the commercial performance of an established portfolio and lead the launch of its first intravesical gene therapy in the UK private market.
Commercial Leadership – Established Products (20%)
* Drive commercial performance of the established portfolio through pricing optimisation, channel strategy and customer segmentation, without a traditional sales‑force model.
* Partner with Digital Marketing to ensure channel execution aligns with commercial objectives.
* Develop and manage annual brand plans, operational plans, and budget cycles for the portfolio.
* Track and report portfolio performance against KPIs to the Business Unit Director and senior leadership.
Private Market Launch – Novel Intravesical Gene Therapy (70%)
* Lead the commercial and market‑access strategy for the 2027 UK private‑market launch.
* Develop and maintain private insurer engagement materials, including budget impact models, clinical dossiers and prior‑authorisation packs.
* Build and manage the relationship between field execution (National KAM) and the broader access strategy.
* Support insurer negotiations and clinical advisory board engagement with Medical Affairs.
* Track private‑market access metrics, insurer coverage status and patient funding approvals.
* Create and maintain market‑access materials for both the established portfolio and launch product.
* Work cross‑functionally with Medical Affairs, Regulatory and Global teams to ensure materials are compliant and fit for purpose.
* Support the development of SMC PACE dossier scoping in collaboration with external health‑economics partners.
Strategic Projects – GM UKIE (10%)
* Act as a trusted commercial lead on selected enterprise‑wide strategic initiatives directed by the GM UKIE.
* Lead business‑development evaluations, commercial due diligence, organisation‑design projects or cross‑BU strategic‑planning exercises.
* Represent the Uro‑Oncology BU perspective in company‑wide forums and leadership discussions.
Qualifications
* Experience in specialty pharmaceutical commercial roles (brand management, portfolio management or market access), ideally within oncology or urology.
* Demonstrable P&L management experience with responsibility for revenue and investment decisions.
* Strong understanding of UK market access—NHS, private market, PMI reimbursement dynamics and insurer engagement.
* Experience developing market‑access materials, value dossiers or payer‑facing content.
* Comfort operating in a lean, hands‑on environment without a large supporting infrastructure.
* Strong analytical and financial literacy—ability to build and interrogate commercial models.
* Excellent stakeholder management and communication skills, credible with senior internal and external audiences.
* Degree‑educated; life sciences or business discipline preferred.
A plus if you also have
* Experience in a non‑sales‑force‑promoted commercial model (digital, pricing, tender or account‑led).
* Exposure to private‑market oncology or urology—insurer engagement, PMI reimbursement or private hospital networks.
* Experience managing or influencing field‑based teams.
* Familiarity with ATMPs, gene therapies or specialty launch products.
* MBA or equivalent postgraduate qualification.
Benefits
* Full P&L ownership from day one—real commercial accountability.
* A ringside seat on one of the most strategically interesting private‑market launches in UK urology.
* Direct line to the Business Unit Director and regular exposure to the GM and senior leadership.
* A genuinely varied role spanning portfolio management, launch strategy, access and strategic projects.
Diversity & Inclusion
We strive to build and maintain an inclusive and diverse workplace with equal opportunities and mutual respect for all employees regardless of their backgrounds and socioeconomic status.
Location: Ferring UK
#J-18808-Ljbffr